Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | BIIB | ARGX | ||
| Company | Alnylam Pharmaceuticals | Biogen Inc | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 247.61 | 225.67 | 466.10 | ||
| High | 247.61 | 227.63 | 471.80 | ||
| Low | 247.61 | 222.38 | 466.10 | ||
| Last | 247.61 | 226.40 | 471.32 | ||
| Change | +9.78 | +1.15 | +4.76 | ||
| % Change | +4.11% | +0.51% | +1.02% | ||
| Volume | 204 | 851,700 | 615,600 | ||
| 20-Day Average Volume | 1,834,160 | 1,022,985 | 397,350 | ||
| Previous Close | 237.83 | 225.25 | 466.56 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 247.31 | 227.65 | 448.64 | ||
| 20-Day Raw Stochastic | 70.42% | 35.48% | 95.46% | ||
| 20-Day Relative Strength | 69.17% | 50.13% | 67.36% | ||
| Weighted Alpha | +14.35 | -15.03 | -2.43 | ||
| Today's Opinion | 88% Buy | 24% Sell | 72% Buy | ||
| Previous Opinion | 72% Buy | 24% Sell | 72% Buy | ||
| Last Month's Opinion | 24% Sell | 24% Sell | 64% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.35% since 07/15/24 | -1.59% since 07/12/24 | +1.05% since 07/12/24 | ||
| Low | 232.47 on 07/18/24 | 220.81 on 07/16/24 | 457.49 on 07/17/24 | ||
| High | 260.90 on 07/16/24 | 231.27 on 07/18/24 | 475.26 on 07/16/24 | ||
| 1-Month | |||||
| %Chg | +49.43% since 06/21/24 | +1.23% since 06/18/24 | +24.70% since 06/18/24 | ||
| Low | 209.23 on 06/24/24 | 220.02 on 06/26/24 | 379.39 on 06/20/24 | ||
| High | 263.73 on 07/12/24 | 238.00 on 07/12/24 | 475.33 on 07/12/24 | ||
| 3-Month | |||||
| %Chg | +69.84% since 04/22/24 | +16.47% since 04/19/24 | +30.84% since 04/19/24 | ||
| Low | 141.98 on 04/25/24 | 192.75 on 04/23/24 | 352.77 on 05/14/24 | ||
| High | 263.73 on 07/12/24 | 238.00 on 07/12/24 | 475.33 on 07/12/24 | ||
| 6-Month | |||||
| %Chg | +34.63% since 01/22/24 | -9.43% since 01/19/24 | +28.46% since 01/19/24 | ||
| Low | 141.98 on 04/25/24 | 189.44 on 04/19/24 | 349.86 on 03/20/24 | ||
| High | 263.73 on 07/12/24 | 252.17 on 01/22/24 | 475.33 on 07/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 30,083,590 | 32,963,160 | 28,011,016 | ||
| Shares Outstanding, K | 126,492 | 145,597 | 59,431 | ||
| Annual Sales | 1,828,290,000 | 9,835,600,000 | 1,268,590,000 | ||
| Annual Net Income | -440,240,000 | 1,161,100,000 | -295,050,000 | ||
| Last Quarter Sales | 494,330,000 | 2,290,500,000 | 412,510,000 | ||
| Last Quarter Net Income | -65,940,000 | 393,400,000 | -61,600,000 | ||
| 60-Month Beta | 0.37 | -0.04 | 0.64 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 05/02/24 | 3.67 on 04/24/24 | -1.04 on 05/09/24 | ||
| Latest Earnings Date | 08/01/24 | 08/01/24 | 07/25/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 15.02 | 0.00 | ||